hypertension, portal

Showing 1 - 25 of 25

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hypertension, Portal, Liver Cirrhosis Trial (Placebo, BI 685509)

Not yet recruiting
  • Hypertension, Portal
  • Liver Cirrhosis
  • Placebo
  • BI 685509
  • (no location specified)
Oct 9, 2023

Liver Diseases, Hypertension, Portal Trial in Wien, Montreal (BI 685509, Empagliflozin)

Recruiting
  • Liver Diseases
  • Hypertension, Portal
  • Pasadena, California
  • +27 more
Jan 24, 2023

Hypertension, Portal, Ascites Trial in Los Angeles (Gore® Viatorr® Endoprosthesis with controlled expansion, Large Volume

Recruiting
  • Hypertension, Portal
  • Ascites
  • Gore® Viatorr® Endoprosthesis with controlled expansion
  • Large Volume Paracentesis with albumin infusion
  • Los Angeles, California
    UCLA Medical Center
Sep 1, 2022

Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient

Completed
  • Liver Cirrhosis
  • +2 more
  • EchoTip® Insight™ Portosystemic Pressure Gradient Measurement System (EchoTip® Insight™)
  • Orange, California
  • +6 more
Jun 17, 2022

Cirrhosis, Splenectomy, Venous Thrombosis Trial in Yangzhou (Apixaban 2.5 MG, Dipyridamole 25Mg Tab, subcutaneous Low Molecular

Recruiting
  • Cirrhosis
  • +3 more
  • Apixaban 2.5 MG
  • +2 more
  • Yangzhou, Jiangsu, China
    Clinical Medical College, Yangzhou University
Apr 30, 2022

Cirrhosis, Splenectomy; Status, Venous Thrombosis Trial in Yangzhou (Apixaban, Warfarin, Aspirin)

Recruiting
  • Cirrhosis
  • +3 more
  • Yangzhou, Jiangsu, China
    Clinical Medical College of Yangzhou University
Mar 19, 2022

Hypertension, Portal Trial in Philadelphia (SHAPE measurement using the ultrasound contrast agent Sonazoid (perfluorobutane

Recruiting
  • Hypertension, Portal
  • SHAPE measurement using the ultrasound contrast agent Sonazoid (perfluorobutane microbubbles)
  • SHAPE measurement using the ultrasound contrast agent Lumason (sulfur hexafluoride lipid-type A microspheres)
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Jan 20, 2022

TIPS Plus Transvenous Obliteration for Gastric Varices

Recruiting
  • Cirrhosis, Liver
  • +4 more
  • TIPS-obliteration
  • Chicago, Illinois
    University of Illinois at Chicago
Nov 18, 2021

Multiparametric Cardio-hepatic MRI in Noncirrhotic Portal

Recruiting
  • Hypertension, Portal
  • Cardiomyopathies
  • Cardiac magnetic resonance scan
  • Bonn, NRW, Germany
  • +1 more
Sep 2, 2021

Portal Hypertension in Cirrhosis (Pan-CHESS1802)

Recruiting
  • Hypertension, Portal
  • HVPG measurement
  • Beijing, China
  • +5 more
Aug 16, 2021

Hypertension, Portal Trial in United States (GR-MD-02, Placebo)

Completed
  • Hypertension, Portal
  • Los Angeles, California
  • +45 more
Oct 6, 2020

Outcome After TIPS

Completed
  • Hypertension, Portal
  • +3 more
  • no intervention - retrospective analyses
  • Graz, Austria
    Medical University of Graz
May 14, 2020

Hypertension, Portal Trial in China, Turkey (Transjugular HVPG measurement, MR imaging)

Completed
  • Hypertension, Portal
  • Transjugular HVPG measurement
  • MR imaging
  • Beijing, Beijing, China
  • +10 more
Aug 26, 2019

Hypertension, Portal Trial in China (HVPG measurement, CTA)

Completed
  • Hypertension, Portal
  • HVPG measurement
  • CTA
  • Beijing, Beijing, China
  • +5 more
Jan 4, 2019

Hypertension, Portal Trial in China (Invasive PPG)

Withdrawn
  • Hypertension, Portal
  • Invasive PPG
  • Beijing, Beijing, China
  • +9 more
Jan 4, 2019

Hypertension, Portal Trial in Beijing, Guangzhou (HVPG measurement, CTA, Doppler ultrasound)

Completed
  • Hypertension, Portal
  • HVPG measurement
  • +2 more
  • Beijing, Beijing, China
  • +2 more
Jan 4, 2019

Liver Cirrhosis, Hypertension, Portal Trial in Shanghai (HVPG measurement)

Unknown status
  • Liver Cirrhosis
  • Hypertension, Portal
  • HVPG measurement
  • Shanghai, China
    Shanghai Ninth People's Hospital, Shanghai Jiao Tong University
Dec 12, 2018

Liver Cirrhosis, Hypertension, Portal Trial in Edinburgh (Serelaxin, Placebo)

Completed
  • Liver Cirrhosis
  • Hypertension, Portal
  • Edinburgh, United Kingdom
    Liver Unit, Royal Infirmary of Edinburgh
Oct 10, 2018

Hypertension, Portal Trial in Ulm (ARFI-elastography and portal vein flow measurement, HVPG-measurement)

Unknown status
  • Hypertension, Portal
  • ARFI-elastography and portal vein flow measurement
  • HVPG-measurement
  • Ulm, Germany
    Universitätsklinikum Ulm
Oct 16, 2017

Hypertension, Portal, Portal Vein, Cavernous Transformation Of Trial in Guangzhou (Percutaneous transhepatic intrahepatic

Unknown status
  • Hypertension, Portal
  • Portal Vein, Cavernous Transformation Of
  • Percutaneous transhepatic intrahepatic portosystemic shunt
  • Guangzhou, Guangdong, China
    Department of Radiology
Nov 10, 2015

Portal Vein, Cavernous Transformation Of, Hypertension, Portal Trial in Guangzhou (Transhepatic portosystemic shunt, 6-French

Unknown status
  • Portal Vein, Cavernous Transformation Of
  • Hypertension, Portal
  • Transhepatic portosystemic shunt
  • +6 more
  • Guangzhou, Guangdong, China
    Department of Radiology
Jul 20, 2015

Follow-up Study of Complications of Acute Pancreatitis

Unknown status
  • Pancreatitis
  • +5 more
    • Nanchang, Jiangxi, China
      the First Affiliated Hospital of Nanchang University
    May 21, 2015

    Cirrhosis, Hypertension, Portal, Bleeding Esophageal Varices Trial in Spain (Simvastatin, Placebo)

    Completed
    • Cirrhosis
    • +3 more
    • Oviedo, Asturias, Spain
    • +14 more
    Mar 18, 2015

    Esophageal and Gastric Varices, Ulcer, Cirrhosis Trial in Tanta (Esophagogastroduodenoscope)

    Unknown status
    • Esophageal and Gastric Varices
    • +3 more
    • Esophagogastroduodenoscope
    • Tanta, Gharbia, Egypt
      Tanta University Hospital
    Oct 2, 2014

    Hepatic Encephalopathy, Hypertension, Portal, Liver Cirrhosis Trial in Botucatu (Erythromycin, Neomycin)

    Unknown status
    • Hepatic Encephalopathy
    • +2 more
    • Botucatu, São Paulo, Brazil
      Faculdade de Medicina de Botucatu - Universidade Estadual Paulis
    Apr 27, 2010